Home › Funds › Renaissance Technologies › ORGO
Renaissance Technologies position in ORGO
ORGANOGENESIS HLDGS INC · Health Care
Latest position (Q2 2026)1.02M sh
Reported value held$2.47M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 369.60K | $5.26M | New |
| Q4 2021 | 125.60K | $1.16M | Reduce |
| Q1 2022 | 345.80K | $2.63M | Add |
| Q2 2022 | 472.20K | $2.30M | Add |
| Q3 2022 | 1.18M | $3.83M | Add |
| Q4 2022 | 1.17M | $3.16K | Reduce |
| Q1 2023 | 1.25M | $2.66K | Add |
| Q2 2023 | 706.10K | $2.34K | Reduce |
| Q3 2023 | 684.09K | $2.17K | Reduce |
| Q4 2023 | 857.73K | $3.51K | Add |
| Q1 2024 | 807.10K | $2.29K | Reduce |
| Q2 2024 | 795.70K | $2.23M | Reduce |
| Q3 2024 | 817.90K | $2.34M | Add |
| Q4 2024 | 1.07M | $3.44M | Add |
| Q1 2025 | 1.04M | $4.51M | Reduce |
| Q2 2025 | 803.90K | $2.94M | Reduce |
| Q3 2025 | 821.50K | $3.47M | Add |
| Q4 2025 | 818.70K | $4.24M | Hold |
| Q1 2026 | 1.07M | $2.53M | Add |
| Q2 2026 | 1.02M | $2.47M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ORGO
- Morgan Stanley 11.72M sh · $28.48M · Q2 2026
- Vanguard Group 4.96M sh · $25.69M · Q4 2025
- BlackRock Inc 7.25M sh · $17.62M · Q2 2026
- AQR Capital Management 3.01M sh · $7.32M · Q2 2026
- D. E. Shaw & Co 2.89M sh · $7.02M · Q2 2026
- Geode Capital Management 1.94M sh · $4.70M · Q2 2026
- Deutsche Bank AG 1.71M sh · $4.15M · Q2 2026
- Charles Schwab Investment Management 905.02K sh · $2.20M · Q2 2026
- Goldman Sachs Group 887.40K sh · $2.16M · Q2 2026
- Citadel Advisors 867.93K sh · $2.11M · Q2 2026
- Northern Trust Corp 584.58K sh · $1.42M · Q2 2026